0001104659-23-108814.txt : 20231012
0001104659-23-108814.hdr.sgml : 20231012
20231012160540
ACCESSION NUMBER: 0001104659-23-108814
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231010
FILED AS OF DATE: 20231012
DATE AS OF CHANGE: 20231012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENTSUR RON
CENTRAL INDEX KEY: 0001251213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 231322785
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
STREET 2: 20TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2328332-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-10
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001251213
BENTSUR RON
C/O NUVECTIS PHARMA, INC.
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
1
1
0
Chairman & CEO
0
Common Stock
2023-10-10
4
P
0
640
11.08
A
3237484
D
Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.81 to $11.6243. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 426,759 shares of restricted stock.
/s/ Ron Bentsur
2023-10-12